Moreover, blockade of Smad2/3 signaling increased chemo-sensitivity to MMC and GEM in TRIM9 overexpressed cells (Fig. 3E and F), indicating that TRIM9 upregulated Smad2/3 to facilitate bladder cancer development and chemoresistance. Here, SMAD2 is linked to urinary bladder cancer.